DOI QR코드

DOI QR Code

Bannayan-Riley-Ruvalcaba Syndrome in a Patient with a PTEN Mutation Identified by Chromosomal Microarray Analysis: A Case Report

  • Lee, Sun Hwa (Department of Pediatrics, Gachon University Gil Medical Center) ;
  • Ryoo, Eell (Department of Pediatrics, Gachon University Gil Medical Center) ;
  • Tchah, Hann (Department of Pediatrics, Gachon University Gil Medical Center)
  • Received : 2015.12.13
  • Accepted : 2016.04.06
  • Published : 2017.03.30

Abstract

Bannayan-Riley-Ruvalcaba syndrome (BRRS) is one of the phosphatase and tensin homolog hamartoma tumor syndrome with a PTEN gene mutation. It is a rare dominant autosomal disorder characterized by cutaneous lipomas, macrocephaly, intestinal polyps, and developmental delay. Diagnosing this syndrome is important, because it may represent the pediatric phenotype of Cowden syndrome, in which there is an increased risk for malignant tumors in children. Until now, the prevalence of BRRS is unknown. Several dozen cases have been reported in the medical literature, but no case has been reported in Korea. Here we report a case of a 19-year-old girl who was diagnosed with BRRS because of macrocephaly, intellectual disability, and intestinal polyps. Her mother had similar findings and a PTEN mutation. Neither patient had mutations detected by conventional mutation-detection techniques, but a PTEN gene deletion was demonstrated by chromosomal microarray analysis.

Keywords

References

  1. Buisson P, Leclair MD, Jacquemont S, Podevin G, Camby C, David A, et al. Cutaneous lipoma in children: 5 cases with Bannayan-Riley-Ruvalcaba syndrome. J Pediatr Surg 2006;41:1601-3. https://doi.org/10.1016/j.jpedsurg.2006.05.013
  2. Schreibman IR, Baker M, Amos C, McGarrity TJ. The hamartomatous polyposis syndromes: a clinical and molecular review. Am J Gastroenterol 2005;100:476-90. https://doi.org/10.1111/j.1572-0241.2005.40237.x
  3. Bannayan GA. Lipomatosis, angiomatosis, and macrencephalia. A previously undescribed congenital syndrome. Arch Pathol 1971;92:1-5.
  4. Genetics Home Reference. Bannayan-Riley-Ruvalcaba syndrome [Internet]. Bethesda: U. S. National Library of Medicine; 2012 [cited 2016 Mar 13]. Available from: https://ghr.nlm.nih.gov/condition/bannayan-rileyruvalcaba-syndrome.
  5. Genetics Home Reference. Cowden syndrome [Internet]. Bethesda: U. S. National Library of Medicine; 2012 [cited 2016 Mar 13]. Available from: https://ghr.nlm.nih.gov/condition/cowden-syndrome.
  6. Blumenthal GM, Dennis PA. PTEN hamartoma tumor syndromes. Eur J Hum Genet 2008;16:1289-300. https://doi.org/10.1038/ejhg.2008.162
  7. Marsh DJ, Coulon V, Lunetta KL, Rocca-Serra P, Dahia PL, Zheng Z, et al. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet 1998;7:507-15. https://doi.org/10.1093/hmg/7.3.507
  8. Parisi MA, Dinulos MB, Leppig KA, Sybert VP, Eng C, Hudgins L. The spectrum and evolution of phenotypic findings in PTEN mutation positive cases of Bannayan-Riley-Ruvalcaba syndrome. J Med Genet 2001;38:52-8. https://doi.org/10.1136/jmg.38.1.52
  9. Latiff ZA, Atmawidjaja RW, RajaLope RJ, Syed Omar SA, Syed Zakaria SZ, Jamal RA. Bannayan Riley Ruvalcaba syndrome. Ann Acad Med Singap 2010;39:578-82.
  10. Lachlan KL, Lucassen AM, Bunyan D, Temple IK. Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers. J Med Genet 2007;44:579-85. https://doi.org/10.1136/jmg.2007.049981
  11. Hobert JA, Eng C. PTEN hamartoma tumor syndrome: an overview. Genet Med 2009;11:687-94. https://doi.org/10.1097/GIM.0b013e3181ac9aea
  12. Gontijo GM, Pinto CA, Rogatto SR, Cunha IW, Aguiar S Jr, Alves CA. Bannayan-Riley-Ruvalcaba syndrome with deforming lipomatous hamartomas in infant--case report. An Bras Dermatol 2013;88:982-5. https://doi.org/10.1590/abd1806-4841.20132730
  13. Zhou XP, Waite KA, Pilarski R, Hampel H, Fernandez MJ, Bos C, et al. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. Am J Hum Genet 2003;73:404-11. https://doi.org/10.1086/377109
  14. Eng C. PTEN hamartoma tumor syndrome (PHTS) [Internet]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews. Seattle: University of Washington; 2001 Nov 29 [updated 2014 Jan 23; cited 2016 Mar 13]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1488/.
  15. Shaffer LG, Bejjani BA. Using microarray-based molecular cytogenetic methods to identify chromosome abnormalities. Pediatr Ann 2009;38:440-7. https://doi.org/10.3928/00904481-20090723-08
  16. Menko FH, Kneepkens CM, de Leeuw N, Peeters EA, Van Maldergem L, Kamsteeg EJ, et al. Variable phenotypes associated with 10q23 microdeletions involving the PTEN and BMPR1A genes. Clin Genet 2008;74:145-54. https://doi.org/10.1111/j.1399-0004.2008.01026.x
  17. Seo EJ. Clinical applications of chromosomal microarray analysis. J Genet Med 2010;7:111-8. https://doi.org/10.5734/JGM.2010.7.2.111
  18. Manning M, Hudgins L; Professional Practice and Guidelines Committee. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med 2010;12:742-5. https://doi.org/10.1097/GIM.0b013e3181f8baad
  19. Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010;86:749-64. https://doi.org/10.1016/j.ajhg.2010.04.006

Cited by

  1. The Rare Neurocutaneous Disorders: Update on Clinical, Molecular, and Neuroimaging Features vol.27, pp.6, 2017, https://doi.org/10.1097/rmr.0000000000000185